Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Newsummit Biopharma
Shanghai, Shanghai Shi, Chinapitchbook.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Shanghai Newsummit Biopharma Group Co. Ltd. is a private Chinese biotech/pharmaceutical company based in Shanghai, founded in 2001. It operates as both a drug developer and a collaborative research organization, providing R&D services and investment for new drug development projects across China. The company’s pipeline includes recombinant protein therapeutics such as fusion proteins and growth factors targeting indications like burns and breast cancer, with at least one asset reaching Phase 3 clinical trials. It has established partnerships with international companies to co-develop therapies for the Chinese market.
- Therapeutic areas
- OncologyDermatology
- Modalities
- Fusion proteinsGrowth factorsRecombinant proteins
- Industry
- Biotech
02
Partnerships
Pacgen Biopharmaceuticals Corporation – collaboration on PAC‑113 oral candidiasis therapy development for China marketIndiso Ltd – partnership on respiratory disease therapy clinical trials using Indiso Speleo Therapy technology in China
Beyond the preview
Go deeper on Shanghai Newsummit Biopharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shanghai Newsummit Biopharma.